Cargando…
Synergistic Reactivation of Latent HIV Expression by Ingenol-3-Angelate, PEP005, Targeted NF-kB Signaling in Combination with JQ1 Induced p-TEFb Activation
Although anti-retroviral therapy (ART) is highly effective in suppressing HIV replication, it fails to eradicate the virus from HIV-infected individuals. Stable latent HIV reservoirs are rapidly established early after HIV infection. Therefore, effective strategies for eradication of the HIV reservo...
Autores principales: | Jiang, Guochun, Mendes, Erica A., Kaiser, Philipp, Wong, Daniel P., Tang, Yuyang, Cai, Ivy, Fenton, Anne, Melcher, Gregory P., Hildreth, James E. K., Thompson, George R., Wong, Joseph K., Dandekar, Satya |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4520526/ https://www.ncbi.nlm.nih.gov/pubmed/26225771 http://dx.doi.org/10.1371/journal.ppat.1005066 |
Ejemplares similares
-
The Protein Kinase C Agonist PEP005 (Ingenol 3-Angelate) in the Treatment of Human Cancer: A Balance between Efficacy and Toxicity
por: Ersvaer, Elisabeth, et al.
Publicado: (2010) -
Antiproliferative activity of PEP005, a novel ingenol angelate that modulates PKC functions, alone and in combination with cytotoxic agents in human colon cancer cells
por: Benhadji, K A, et al.
Publicado: (2008) -
Targeting Cutaneous T-Cell Lymphoma Cells by Ingenol Mebutate (PEP005) Correlates with PKCδ Activation, ROS Induction as Well as Downregulation of XIAP and c-FLIP
por: Sumarni, Uly, et al.
Publicado: (2021) -
Treatment of superficial basal cell carcinoma with ingenol mebutate gel, 0.05%
por: Bettencourt, Miriam S
Publicado: (2016) -
RasGRPs Are Targets of the Anti-Cancer Agent Ingenol-3-Angelate
por: Song, Xiaohua, et al.
Publicado: (2013)